Center | Stanford University |
Award Year | 2019 |
Pilot Study | Targeting KIR+ Regulatory CD8+ T cells in Type 1 Diabetes |
Awardee | Mark Davis PhD |
- Home
- Pilot & Feasibility
- P&F Studies
- Targeting KIR+ Regulatory CD8+ T cells in Type 1 Diabetes
Center | Stanford University |
Award Year | 2019 |
Pilot Study | Targeting KIR+ Regulatory CD8+ T cells in Type 1 Diabetes |
Awardee | Mark Davis PhD |